0000950170-23-054142.txt : 20231019
0000950170-23-054142.hdr.sgml : 20231019
20231019150835
ACCESSION NUMBER: 0000950170-23-054142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231017
FILED AS OF DATE: 20231019
DATE AS OF CHANGE: 20231019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BB BIOTECH AG
CENTRAL INDEX KEY: 0000924223
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39200
FILM NUMBER: 231334576
BUSINESS ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
BUSINESS PHONE: 411724 59 59
MAIL ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIOTECH GROWTH N V
CENTRAL INDEX KEY: 0001259869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39200
FILM NUMBER: 231334577
MAIL ADDRESS:
STREET 1: ARA HILL TOP BUILDING, UNIT A-5
STREET 2: PLETTERIJWEG OOST 1, CURACAO
CITY: WILLEMSTAD
STATE: P8
ZIP: 000000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701541
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-417-5868
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aset Therapeutics, Inc.
DATE OF NAME CHANGE: 20170321
4
1
ownership.xml
4
X0508
4
2023-10-17
0001701541
Black Diamond Therapeutics, Inc.
BDTX
0001259869
BIOTECH GROWTH N V
ARA HILL TOP BUILDING, UNIT A-5
PLETTERIJWEG OOST 1
CURACAO
P8
000000
NETHERLANDS ANTILLES
false
false
true
false
0000924223
BB BIOTECH AG
SCHWERTSTRASSE 6
SCHAFFHAUSEN
V8
CH-8200
SWITZERLAND
false
false
true
false
false
Common Stock
2023-10-17
4
P
false
400000
2.3352
A
8517839
D
Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.
/s/ Ivo Betschart
2023-10-19
/s/ Martin Gubler
2023-10-19